Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Serious Health Threat of Mucormycosis During the Ongoing Covid-19 Pandemic: What Dermatologists Need to Know in This Regard Publisher Pubmed



Hatami P1 ; Balighi K1, 2 ; Nicknam Asl H3 ; Aryanian Z1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Dentistry, Rafsanjan University of Medical Sciences (RUMS), Rafsanjan, Iran
  4. 4. Department of Dermatology, Babol University of Medical Sciences, Babol, Iran

Source: International Journal of Dermatology Published:2022


Abstract

Background: Recently, a surge of mucormycosis in patients affected with or recovered from SARS-Cov-2 has been noted, especially in developing countries such as India, Pakistan, and Iran. Aim: To focus on existing data about the important aspects of COVID-associated mucormycosis. Methods: We searched on PubMed, Google Scholar, and Scopus in this regard, and all of the relevant papers published until August 28, 2021, for which we could access their full-texts, were included. Results: We found some recommendations made by ophthalmologists, anesthesiologists, and ENT surgeons and tried to summarize them to provide a practical guide for dermatologists. Conclusion: Careful examination and clinical suspicion are the key factors for correct diagnosis especially in patients affected by or recently recovered from COVID. Implementing some preventive measures such as using a titrated dose of corticosteroids and encouraging patients to get vaccinated should be considered to tackling this serious issue. © 2022 the International Society of Dermatology.
Other Related Docs